If you need more lookups,
subscriptions start at $34 USD/month.
Devashish Das Location
Seoul, South Korea
Devashish Das Work
2018 -now Researcher @
2017 -2018 Lead Scientist @
2015 -2018 Research Scientist @ Durga Femto Technologies and Research (DFTR)
2014 -2017 Head of Academic Programs @
2016 -2017 Research Consultant (Molecular Dynamics) @ OpexLabs
2015 -2016 Research Consultant @
2014 -2014 Research Intern @
2013 -2014 Editorial Advisor @
2012 -2012 Research Executive @
2010 -2012 Project Co-ordinator @ Aarupadai Veedu Medical College
2011 -2011 Trainee @
Devashish Das Education
Siddaganga Institute of Technology, Tumkur
PG Deploma (Bioinformatics & Rational Drug Designing)
2013-2014
Siddaganga Institute of Technology, Tumkur
PG Deploma (Bioinformatics)
2013-2014
Vinayaka Mission's Research Foundation - University
BE (Biotechnology)
2008-2012
Kendriya Vidyalaya 1994-2004
Devashish Das Skills
Drug Discovery
Drug Design
Systems Biology
Biotechnology
Bioinformatics
Molecular Biology
Protein Chemistry
Genomics
Docking
Research
Molecular Modeling
3D rendering
SDS-PAGE
Cell Culture
DNA extraction
Python
Microarray Analysis
NGS
R
Bioconductor
Biomedical Engineering
Innovation
Team Leadership
R&D
DNA
Pymol
Lifesciences
Microbiology
Chromatography
Protein Purification
Proteomics
DNA sequencing
Life Sciences
Biochemistry
Research and Development (R&D)
Devashish Das Summary
Devashish Das, based in Seoul, South Korea, is currently a Researcher at Konkuk University. Devashish Das brings experience from previous roles at DNASKEW, Durga Femto Technologies and Research (DFTR), Educept: An Initiative of Eevolve Indiaservices Pvt.Ltd and OpexLabs. Devashish Das holds a 2013 - 2014 PG Deploma in Bioinformatics & Rational Drug Designing @ Siddaganga Institute of Technology, Tumkur. With a robust skill set that includes Drug Discovery, Drug Design, Systems Biology, Biotechnology, Bioinformatics and more. Devashish Das has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Devashish Das?
Find contact details for 700 million professionals.